Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,916
Total Claims
$1.0M
Drug Cost
636
Beneficiaries
$1,594
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+13%
Cost per patient vs peers
$1,594 vs $1,411 avg
+1%
Brand preference vs peers
10.7% vs 10.6% avg
Brand vs Generic
Brand: 951 claims · $311K
Generic: 7,944 claims · $701K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Desvenlafaxine Succinate | 446 | $250K |
| Aripiprazole | 247 | $127K |
| Fluticasone Propion/Salmeterol | 174 | $73K |
| Celecoxib | 214 | $57K |
| Cyclobenzaprine Hcl | 126 | $54K |
| Quetiapine Fumarate | 102 | $48K |
| Solifenacin Succinate | 147 | $40K |
| Rsvpref3 Antigen/As01e/Pf | 114 | $34K |
| Nebivolol Hcl | 187 | $25K |
| Pioglitazone Hcl/Metformin Hcl | 148 | $24K |
| Varicella-Zoster Ge/As01b/Pf | 120 | $24K |
| Diphth,pertuss(Acell),tet Vac | 297 | $20K |
| Atenolol/Chlorthalidone | 174 | $14K |
| Dutasteride | 69 | $12K |
| Olanzapine | 86 | $11K |
Prescribing Profile
Patient Profile
63
Avg Age
62%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data